ℹ️ Compiled from public regulatory records · Last regulator revision: February 24, 2026🚩 Report this page

Silodosin

Alpha-Adrenoreceptor Antagonists

Sold as Urorec · Silodyx

CA Health CanadaEU EMA

Drug class: Alpha-Adrenoreceptor Antagonists
Availability: See label
Routes: Oral
Markets covered: 2
Products on record: 16

Overview

Silodosin is an active pharmaceutical ingredient in the Alpha-Adrenoreceptor Antagonists group (G04CA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.

Regulatory status by market

Market	Regulator	Products	Last revision
CA Canada	Health Canada	13	February 24, 2026
EU European Union	EMA	3	May 7, 2025

CACanada· Health Canada

13 products

Uses

CAOfficial regulatory label· revised March 22, 2025[1]

AND CLINICAL USE .................................................................................... 3 CONTRAINDICATIONS ......................................................................................................... 3 WARNINGS AND PRECAUTIONS .......................................................................................
4 ADVERSE REACTIONS ......................................................................................................... 6 DRUG INTERACTIONS ..........................................................................................................
9 DOSAGE AND ADMINISTRATION .................................................................................... 11 OVERDOSAGE ......................................................................................................................
12 ACTION AND CLINICAL PHARMACOLOGY .................................................................. 13 STORAGE AND STABILITY ............................................................................................... 17 SPECIAL HANDLING INSTRUCTIONS .............................................................................

EUEuropean Union· EMA

3 products

Uses

EUOfficial regulatory label· revised May 7, 2025[2]

Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) in adult men.

How to take

EUOfficial regulatory label

Drug interactions

Known interactions involving Silodosin. Select one for details. This list is informational and not a complete interaction checker.

Amprenavir Atazanavir Boceprevir Ceritinib Clarithromycin Cobicistat Conivaptan Delavirdine Fosamprenavir Idelalisib Indinavir Itraconazole Ketoconazole Lonafarnib Nefazodone Nelfinavir Posaconazole Ritonavir Saquinavir Telaprevir Telithromycin Troleandomycin Tucatinib Voriconazole Abametapir Acebutolol Alfentanil Alfuzosin Alpelisib Alprazolam Amifostine Aminoglutethimide Amiodarone Amisulpride Amitriptyline Amobarbital Amoxapine Apalutamide Apraclonidine Aprepitant Aripiprazole Armodafinil Atenolol Avanafil Baclofen Benazepril Benzhydrocodone Bepridil Berotralstat Betaxolol Bexarotene Bicalutamide Bisoprolol Bosentan Brexpiprazole Brigatinib Brimonidine Buprenorphine Bupropion Buspirone Butabarbital Butalbital Butorphanol Cabergoline Cabozantinib Canagliflozin Capmatinib Captopril Carbamazepine Cariprazine Carisoprodol Carteolol Carvedilol Cenobamate Chloramphenicol Chlordiazepoxide Chlormezanone Chlorphenesin Chlorpromazine Chlorzoxazone Cimetidine Ciprofloxacin Clobazam Clomipramine Clonazepam Clorazepate Clotrimazole Codeine Crizotinib Cyclobenzaprine Cyclosporine Dabrafenib Daclatasvir Dalfopristin Danazol Dapagliflozin Darunavir Dasatinib Deferasirox Desipramine Dexamethasone Dexmedetomidine Dezocine Diazepam Dichloralphenazone Dihydrocodeine Diltiazem Dimenhydrinate Diphenhydramine Doravirine Doxazosin Doxepin Dronabinol Dronedarone Duvelisib Efavirenz Eliglustat Empagliflozin Enalapril Encorafenib Entrectinib Enzalutamide Erdafitinib Ertugliflozin Erythromycin Eslicarbazepine Esmolol Ethanol Ethchlorvynol Etravirine Fedratinib Felbamate Felodipine Fentanyl Flibanserin Fluconazole Fluphenazine Flurazepam Fluvoxamine Fosaprepitant Fosinopril Fosphenytoin Fostamatinib Gilteritinib Glasdegib Glycerol Phenylbutyrate Grepafloxacin Griseofulvin Guanfacine Halazepam Haloperidol Hydrocodone Hydromorphone Hydroxyzine Ibrutinib Imatinib Imipramine Isavuconazonium Isocarboxazid Isoniazid Istradefylline Ivacaftor Ivosidenib Labetalol Lapatinib Larotrectinib Lasmiditan Ledipasvir Lefamulin Lemborexant Lesinurad Letermovir Levobetaxolol Levobunolol Levorphanol Linezolid Lisinopril Lithium Carbonate Lomitapide Lorazepam Lorlatinib Loxapine Lumacaftor Lumateperone Lurasidone Maprotiline Meperidine Mephobarbital Meprobamate Mesoridazine Metaxalone Methadone Methdilazine Methocarbamol Metipranolol Metoprolol Metreleptin Miconazole Midazolam Midostaurin Mifepristone Minoxidil Mirtazapine Mitotane Modafinil Moexipril Molindone Morphine Nabilone Nadolol Nafcillin Nalbuphine Nebivolol Neratinib Netupitant Nevirapine Nicardipine Nilotinib Nortriptyline Oliceridine Opium Oritavancin Orphenadrine Oxazepam Oxcarbazepine Oxycodone Oxymorphone Ozanimod Palbociclib Paraldehyde Pazopanib Penbutolol Pentazocine Pentobarbital Pentoxifylline Perindopril Perphenazine Pexidartinib Phenelzine Phenobarbital

Showing 240 of 327. Type above to find a specific drug.

Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.

Sources & citations

[1]Health Canada (DPD) · 02479850 · revised March 22, 2025
[2]European Medicines Agency · EMEA/H/C/001092 · revised May 7, 2025

Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.